NEWS3 December 2010

Cegedim and SDI launch oncology audit

North America

US— Healthcare researchers SDI and Cegedim Strategic Data have teamed up to launch a new service that tracks selling activities in the oncology therapeutic market.

The new Oncology Selling Audit will launch in January and contain data from a sample of medical and radiation oncologists and haematologists.

The monthly service will provide nationally projected measures of personal selling in the oncology market, including competitive corporate calls, messages and promotional spending. Sectors covered include tumour type, staging and modalities.

Cegedim’s COO for sales and marketing Bruno Lempernesse said: “We are pleased to be partnering with SDI to bring this key service to the marketplace. This launch reaffirms the commitment to innovation that both organisations bring to healthcare measurement. This partnership will benefit from CSD’s global experience in promotion audits and allow for more in-depth analysis of sales and marketing strategies for all cancer treatments.”